allergic rhinitis symptoms
Item
allergic rhinitis symptoms: sneezing, rhinorrhea, obstruction of the nasal passages, itchy nose and throat, and conjunctival
boolean
C2607914 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0037383 (UMLS CUI [2])
C0027429 (UMLS CUI [3])
C0850060 (UMLS CUI [4])
C0700184 (UMLS CUI [5])
outpatient, age
Item
male or female outpatient 20 years of age and older
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
asthma and allergic rhinitis symptoms
Item
patients with the following signs and symptoms of asthma and allergic rhinitis: history of cough, wheezing, shortness of breath, positive methacholine bronchoprovocation test
boolean
C0004096 (UMLS CUI [1])
C2607914 (UMLS CUI [2])
C0430567 (UMLS CUI [3,1])
C1446409 (UMLS CUI [3,2])
C0010200 (UMLS CUI [4])
C0043144 (UMLS CUI [5])
C0013404 (UMLS CUI [6])
pulmonary disorder
Item
active, acute or chronic, pulmonary disorder (besides asthma) documented by history, physical examination, or chest x-ray. history of anaphylactic or hypersensitive to study drug
boolean
C1096000 (UMLS CUI [1])
corticosteroids daily
Item
requires oral, intravenous, or intramuscular corticosteroids on daily routine basis
boolean
C0001617 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
immunotherapy
Item
started on immunotherapy within six months before the pre-study visit and/or the dose of immunotherapy is expected to change over the course of the study
boolean
C0021083 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
montelukast
Item
treated with montelukast within 3 months before enrollment
boolean
C0298130 (UMLS CUI [1])
unable to perform acceptable, reproducible spirometry and peak flow measurement
Item
unable to perform acceptable, reproducible spirometry and peak flow measurement
boolean
C1321605 (UMLS CUI [1])
C0037981 (UMLS CUI [2])
C0521299 (UMLS CUI [3])
upper respiratory tract infection
Item
unresolved symptoms and signs of an upper respiratory tract infection (uri) within 2 weeks prior to visit 1
boolean
C0041912 (UMLS CUI [1])